Skip to main content
. 2021 Nov 8;6:73. doi: 10.1038/s41536-021-00181-9

Table 4.

Adverse effects.

Adverse effects Articles
AE related to mesenchymal cell therapy 14,16,17,23,31,33,38
AE not related to mesenchymal cell therapy 13,16,17,19,21,2527,29,30,32,38,63
AE during the infusion 16,17,31,33
No AE 11,12,15,18,20,22,24,28,3437
AE related to mesenchymal cell therapy Articles
Worsening of Bradycardia 14

Hypoxemia

Hypotension and/or hypertension

Muscle spasms

16

Transient facial flushing

Fever

17

Liver dysfunction

Heart failure

Allergic rash

23

Diarrhea

Rash in the chest area

31
Single CTCAE grade 1 33
Transient shivering 38
AE not related to mesenchymal cell therapy Articles

Repeated pulmonary infections

Empyema

13

Lower-extremity arterial thrombosis

Epistaxis and hematuria

16
Hypoxemia 17
Pneumothorax 19

Bacterial pneumonia

Septic shock

21
Nosocomial pneumonia 25

Respiratory arrest

Sepsis

Embolic infarcts

26
Cardiopulmonary arrest 27,38

Hypoxic respiratory failure

Pulmonary embolism

Acute renal failure

Expiration

29
Disseminated fungal infection and intra-abdominal sepsis 30

Massive gastrointestinal bleeding

Hypotension

Tachycardia

Pneumonia

Fungal infection by Candida spp.

32
Lung transplant rejection 63